Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × Radiofrequency Ablation × Clear all

Sponsor

Conditions

Liver Neoplasms 5 Carcinoma, Hepatocellular 5 Neoplasm Metastasis 3 Biliary Tract Neoplasms 2 Squamous Intraepithelial Lesions 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Osteosarcoma 1 Lung Neoplasms 1 Hepatitis B, Chronic 1 HIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-Grade Squamous Intraepithelial Lesions 1 Esophageal Squamous Cell Neoplasia (ESCN) 1 Esophageal Squamous Cell Carcinoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bile Duct Neoplasms 1 Barrett Esophagus 1 Adrenal Gland Neoplasms 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Ipilimumab 79 pembrolizumab 71 Nivolumab 68 aldesleukin 46 Cyclophosphamide 44 Interleukin-2 33 fludarabine phosphate 30 Vemurafenib 29 Dacarbazine 28 trametinib 25 fludarabine 25 dabrafenib 25 Temozolomide 21 Bevacizumab 15 Radiosurgery 14 binimetinib 12 Paclitaxel 12 Introns 12 Interferon alpha-2 12 Carboplatin 11 CTLA-4 Antigen 11 peginterferon alfa-2b 9 montanide ISA 51 9 encorafenib 9 cobimetinib 9 Radiotherapy 9 talimogene laherparepvec 8 atezolizumab 8 Sorafenib 8 spartalizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡